Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL) Meeting Abstract


Authors: Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; Yahalom, J.; Rademaker, J.; Dogan, A.; Seshan, V.; Younes, A.
Abstract Title: Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
Meeting Title: 15th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 37
Issue: Suppl. 2
Meeting Dates: 2019 Jun 18-22
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2019-06-01
Start Page: 331
End Page: 332
Language: English
ACCESSION: 137029154
DOI: 10.1002/hon.143_2630
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 31187525
DOI/URL:
Notes: Meeting abstract: 279 -- Accession Number: 137029154 -- Entry Date: In Process -- Revision Date: 20190620 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Venkatraman Ennapadam Seshan
    385 Seshan
  2. Joachim Yahalom
    633 Yahalom
  3. Craig Moskowitz
    407 Moskowitz
  4. Alison Moskowitz
    354 Moskowitz
  5. Matthew J Matasar
    292 Matasar
  6. Philip C Caron
    100 Caron
  7. Connie Wing-Ching Lee Batlevi
    177 Batlevi
  8. Anas Younes
    320 Younes
  9. Ahmet Dogan
    467 Dogan
  10. Santosha Adipudi Vardhana
    112 Vardhana
  11. David Sermer
    12 Sermer
  12. Erin Biggar
    6 Biggar
  13. Echo Leung
    1 Leung